Cell Growth & Differentiation, Vol 8, Issue 7 731-742, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2

K Yu, CP Ravera, YN Chen and G McMahon
Oncology Research Program, Preclinical Research, Sandoz Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA.

Deregulated overexpression of c-Myc (Myc) confers susceptibility to apoptosis in several cell types, but the molecular regulation of these processes has not been well established. Here we have characterized several molecular changes that may modulate Myc-dependent apoptosis. Ectopic overexpression of Myc in both Rat1 fibroblasts and human osteosarcoma cells causes a dramatic increase of cellular p53 mRNA and protein, and this induction of p53 correlates with apoptosis triggered by withdrawal of serum. Stable transfection of a wild-type human p53 gene into Myc-transformed cells further potentiates apoptosis. Anticancer agents vinblastine and nocodazole also induce apoptosis in Myc-transformed Rat1 fibroblasts but are cytostatic to the same cells without Myc overexpression. We demonstrate that induction of Myc-dependent apoptosis in these cells is specifically associated with an activation of p46 c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activity, whereas this JNK/SAPK activation is absent in stress-treated cells without Myc overexpression. Moreover, overexpression of the Mdm-2 gene in Rat1-myc cells significantly inhibits apoptosis induced by low serum but has little effect on apoptosis triggered by chemotherapeutic drugs. Interestingly, differential inhibition by Mdm-2 paralleled differential activation of p46 JNK/SAPK. Thus, our data support a functional involvement of p53 in Myc-dependent apoptosis and implicate potential regulatory roles for JNK/SAPK and Mdm-2 pathways in the regulation of apoptosis in Myc-transformed tumor cells.

This article has been cited by other articles:

				M. SHERMAN and G. MULTHOFF Heat Shock Proteins in Cancer Ann. N.Y. Acad. Sci., October 1, 2007; 1113(1): 192 - 201. [Abstract] [Full Text] [PDF]

				C. Hecquet, G. Lefevre, M. Valtink, K. Engelmann, and F. Mascarelli Activation and Role of MAP Kinase-Dependent Pathways in Retinal Pigment Epithelium Cells: JNK1, P38 Kinase, and Cell Death Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1320 - 1329. [Abstract] [Full Text] [PDF]

				R. G. Deschesnes, J. Huot, K. Valerie, and J. Landry Involvement of p38 in Apoptosis-associated Membrane Blebbing and Nuclear Condensation Mol. Biol. Cell, June 1, 2001; 12(6): 1569 - 1582. [Abstract] [Full Text] [PDF]

				H. Primdahl, H. von der Maase, M. Christensen, H. Wolf, and T. F. Ørntoft Allelic Deletions of Cell Growth Regulators during Progression of Bladder Cancer Cancer Res., December 1, 2000; 60(23): 6623 - 6629. [Abstract] [Full Text]

				S. Kharbanda, S. Saxena, K. Yoshida, P. Pandey, M. Kaneki, Q. Wang, K. Cheng, Y.-N. Chen, A. Campbell, T. Sudha, et al. Translocation of SAPK/JNK to Mitochondria and Interaction with Bcl-xL in Response to DNA Damage J. Biol. Chem., January 7, 2000; 275(1): 322 - 327. [Abstract] [Full Text] [PDF]

				E Cohen, I Ophir, and Y. Shaul Induced differentiation in HT29, a human colon adenocarcinoma cell line J. Cell Sci., January 8, 1999; 112(16): 2657 - 2666. [Abstract] [PDF]